Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
42,271,962
-
Total 13F shares
-
32,110,359
-
Share change
-
-203,373
-
Total reported value
-
$183,344,535
-
Price per share
-
$5.71
-
Number of holders
-
51
-
Value change
-
-$1,268,660
-
Number of buys
-
21
-
Number of sells
-
22
Institutional Holders of Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB) as of Q1 2023
As of 31 Mar 2023,
Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,110,359 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, 5AM Venture Management, LLC, New Leaf Venture Partners, L.L.C., FMR LLC, TPG GP A, LLC, Pivotal bioVenture Partners Investment Advisor LLC, Novo Holdings A/S, Canaan Partners XI LLC, Tekla Capital Management LLC, and VANGUARD GROUP INC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.